Decreased brain noradrenaline in minimal hepatic encephalopathy is associated with cognitive impairment in rats

Xuhong Yang1, Wenxiao Liu1, Pei Dang2

  • 1School of Clinical Medicine, Ningxia Medical University, Yinchuan 750004, China.

Brain Research
|August 9, 2022
PubMed
Abstract

Insights

Minimal hepatic encephalopathy (MHE) in rats with liver failure showed reduced hippocampal noradrenaline levels and impaired cognition. Iron accumulation in the brain may cause these MHE-related changes.

Area of Science:

  • Neuroscience
  • Hepatology
  • Biochemistry

Background:

  • Minimal hepatic encephalopathy (MHE) is a common neuropsychiatric complication in cirrhosis patients.
  • Alterations in monoamine neurotransmitters are implicated in MHE pathogenesis.
  • Investigating hippocampal noradrenergic neurotransmitter alterations in MHE is crucial.

Purpose of the Study:

  • To investigate hippocampal noradrenergic neurotransmitter levels in a rat model of thioacetamide-induced chronic liver failure-related MHE.
  • To explore the role of these neurotransmitters in cognitive impairment associated with MHE.
  • To examine the relationship between iron accumulation, inflammation, and noradrenergic changes in MHE.

Main Methods:

  • Established a thioacetamide (TAA)-induced rat model of chronic liver failure-related MHE over 12 weeks.
  • Assessed cognitive function using the Morris water maze (MWM) and exploratory behavior via open field test.
  • Quantified hippocampal noradrenaline (NE) levels (ELISA), iron content (Prussian blue staining), and magnetic susceptibility.

Main Results:

  • MHE rats exhibited significant cognitive deficits and reduced locomotor activity compared to controls.
  • Pronounced hippocampal iron accumulation was observed in MHE rats, absent in controls.
  • Significantly lower hippocampal noradrenaline levels and altered inflammatory cytokine profiles were found in MHE rats.

Conclusions:

  • Thioacetamide-induced MHE in rats is linked to altered noradrenergic neurotransmission.
  • Brain iron imbalance may contribute to reduced noradrenaline levels and cognitive impairment in MHE.
  • Findings suggest a potential mechanism involving iron dysregulation in MHE pathogenesis.